Breaking News

Guidelines for biologic interventions for psoriasis, 2009

Guidelines for biologic interventions for psoriasis, 2009

 
 

An update to the British Association of Dermatologists 2005 guidelines for biologic interventions for psoriasis was published. The interventions reviewed comprised infliximab, etanercept, adalimumab and ustekinumab. The guidelines discuss definitions of response, eligibility criteria, efficacy, drug combinations, adverse effects and toxicity, pretreatment assessments, and monitoring and transitioning of therapies. Indications for drug cessation and audit points are also reviewed (Smith, C.H. et al. Br J Dermatol 2009, 161: 987).

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list